Anti-cytokine treatments like TNF inhibitors and IL-6 receptor blocker may be considered to interfere with fibroblast contribution to RA, since FLS are activated by both cytokines while they are major producers of IL-6 but not TNF. This evidence concerns the gene IL6 and rheumatoid arthritis.